AUD 0.3
(1.69%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 22.14 Million AUD | -3.25% |
2023 | 22.89 Million AUD | 26.34% |
2022 | 18.11 Million AUD | 10.54% |
2021 | 16.39 Million AUD | 19.35% |
2020 | 13.73 Million AUD | 21.06% |
2019 | 11.34 Million AUD | -1.29% |
2018 | 11.49 Million AUD | 25.23% |
2017 | 9.17 Million AUD | -20.39% |
2016 | 11.52 Million AUD | 10.76% |
2015 | 10.4 Million AUD | 0.45% |
2014 | 10.36 Million AUD | -3.48% |
2013 | 10.73 Million AUD | 0.69% |
2012 | 10.66 Million AUD | 3.01% |
2011 | 10.34 Million AUD | 7.63% |
2010 | 9.61 Million AUD | -3.65% |
2009 | 9.97 Million AUD | -14.23% |
2008 | 11.63 Million AUD | -5.69% |
2007 | 12.33 Million AUD | -20.19% |
2006 | 15.45 Million AUD | 1.68% |
2005 | 15.2 Million AUD | 43.9% |
2004 | 10.56 Million AUD | -12.6% |
2003 | 12.08 Million AUD | -9.78% |
2002 | 13.39 Million AUD | 90.47% |
2001 | 7.03 Million AUD | 60.16% |
2000 | 4.39 Million AUD | 0.0% |
1999 | - AUD | 0.0% |
1998 | - AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 22.65 Million AUD | 0.0% |
2024 FY | 22.13 Million AUD | -3.31% |
2024 Q4 | 22.14 Million AUD | 0.0% |
2023 Q4 | 22.89 Million AUD | 0.0% |
2023 FY | 22.89 Million AUD | 26.34% |
2023 Q2 | 22.85 Million AUD | 0.0% |
2022 Q4 | 18.11 Million AUD | 0.0% |
2022 FY | 18.11 Million AUD | 10.54% |
2022 Q2 | 17.22 Million AUD | 0.0% |
2021 FY | 16.39 Million AUD | 19.35% |
2021 Q4 | 16.39 Million AUD | 0.0% |
2021 Q2 | 13.78 Million AUD | 0.0% |
2020 FY | 13.73 Million AUD | 21.06% |
2020 Q2 | 13.86 Million AUD | 0.0% |
2020 Q4 | 13.73 Million AUD | 0.0% |
2019 FY | 11.34 Million AUD | -1.29% |
2019 Q2 | 10.03 Million AUD | 0.0% |
2019 Q4 | 11.34 Million AUD | 0.0% |
2018 FY | 11.49 Million AUD | 25.23% |
2018 Q2 | 9.29 Million AUD | 0.0% |
2018 Q4 | 11.49 Million AUD | 0.0% |
2017 Q4 | 9.17 Million AUD | 0.0% |
2017 FY | 9.17 Million AUD | -20.39% |
2017 Q2 | 8.35 Million AUD | 0.0% |
2016 Q4 | 11.52 Million AUD | 0.0% |
2016 FY | 11.52 Million AUD | 10.76% |
2016 Q2 | 8.68 Million AUD | 0.0% |
2015 FY | 10.4 Million AUD | 0.45% |
2015 Q4 | 10.4 Million AUD | 0.0% |
2015 Q2 | 10.03 Million AUD | 0.0% |
2014 FY | 10.36 Million AUD | -3.48% |
2014 Q2 | 9.92 Million AUD | 0.0% |
2014 Q4 | 10.36 Million AUD | 0.0% |
2013 Q2 | 9.79 Million AUD | 0.0% |
2013 FY | 10.73 Million AUD | 0.69% |
2013 Q4 | 10.73 Million AUD | 0.0% |
2012 FY | 10.66 Million AUD | 3.01% |
2012 Q4 | 10.66 Million AUD | 0.0% |
2011 FY | 10.34 Million AUD | 7.63% |
2011 Q4 | 10.34 Million AUD | 0.0% |
2010 FY | 9.61 Million AUD | -3.65% |
2010 Q4 | 9.61 Million AUD | 0.0% |
2009 FY | 9.97 Million AUD | -14.23% |
2009 Q4 | 9.97 Million AUD | 0.0% |
2008 FY | 11.63 Million AUD | -5.69% |
2008 Q4 | 11.63 Million AUD | 0.0% |
2007 FY | 12.33 Million AUD | -20.19% |
2007 Q4 | 12.33 Million AUD | 0.0% |
2006 FY | 15.45 Million AUD | 1.68% |
2006 Q4 | 15.45 Million AUD | 0.0% |
2005 Q4 | 15.2 Million AUD | 0.0% |
2005 FY | 15.2 Million AUD | 43.9% |
2004 Q4 | 10.56 Million AUD | 0.0% |
2004 FY | 10.56 Million AUD | -12.6% |
2003 Q4 | 12.08 Million AUD | 0.0% |
2003 FY | 12.08 Million AUD | -9.78% |
2002 FY | 13.39 Million AUD | 90.47% |
2002 Q4 | 13.39 Million AUD | 0.0% |
2001 FY | 7.03 Million AUD | 60.16% |
2001 Q4 | 7.03 Million AUD | 0.0% |
2000 FY | 4.39 Million AUD | 0.0% |
1999 FY | - AUD | 0.0% |
1998 FY | - AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
4DMedical Limited | 49.08 Million AUD | 54.882% |
Adherium Limited | 3.4 Million AUD | -550.12% |
Aroa Biosurgery Limited | 14.77 Million AUD | -49.865% |
Atomo Diagnostics Limited | 1.29 Million AUD | -1611.072% |
Anteris Technologies Ltd | 17.03 Million AUD | -29.983% |
Control Bionics Limited | 2.75 Million AUD | -702.58% |
CardieX Limited | 8.56 Million AUD | -158.668% |
Cochlear Limited | 904.6 Million AUD | 97.552% |
CleanSpace Holdings Limited | 6.94 Million AUD | -218.689% |
Cyclopharm Limited | 13.65 Million AUD | -62.2% |
EMVision Medical Devices Ltd | 5.45 Million AUD | -305.964% |
Nova Eye Medical Limited | 8.55 Million AUD | -158.98% |
HeraMED Limited | 1.5 Million AUD | -1370.711% |
Imricor Medical Systems, Inc. | 25 Million AUD | 11.423% |
ImpediMed Limited | 6.24 Million AUD | -254.765% |
InhaleRx Limited | 911.41 Thousand AUD | -2330.073% |
LBT Innovations Limited | 5.5 Million AUD | -302.106% |
Micro-X Limited | 12.63 Million AUD | -75.305% |
Neurotech International Limited | 314.69 Thousand AUD | -6937.836% |
OncoSil Medical Limited | 1.98 Million AUD | -1017.46% |
PolyNovo Limited | 37.04 Million AUD | 40.21% |
Respiri Limited | 3.55 Million AUD | -523.189% |
SomnoMed Limited | 24.78 Million AUD | 10.623% |
Universal Biosensors, Inc. | 10.61 Million AUD | -108.696% |
Uscom Limited | 2.07 Million AUD | -968.107% |
Visioneering Technologies, Inc. | 2.76 Million AUD | -700.46% |